Stroke is a leading cause of morbidity and mortality globally, necessitating prompt recognition and management. This article elucidates the early signs of stroke and provides a comprehensive guide for its management.
Stroke symptoms often appear suddenly and primarily involve neurological deficits. The acronym FAST (Face drooping, Arm weakness, Speech difficulties, and Time to call emergency services) is a quick tool for identification. Other symptoms may include confusion, visual disturbances, dizziness, and severe headache. Early recognition is crucial as it directly affects the prognosis.
Upon suspecting a stroke, healthcare professionals should conduct a rapid assessment using validated tools such as the National Institutes of Health Stroke Scale (NIHSS). This is followed by immediate stabilization of vital signs, securing an airway if needed, and obtaining a non-contrast CT scan to differentiate between ischemic and hemorrhagic stroke.
Ischemic strokes can be managed with intravenous thrombolytics if presented within 4.5 hours of symptom onset. Endovascular thrombectomy is considered for large vessel occlusions. Hemorrhagic strokes require control of blood pressure, reversal of anticoagulation, and neurosurgical consultation. Both types necessitate secondary prevention strategies, including risk factor modification and antithrombotic therapy.
Post-stroke care involves a multidisciplinary team, including physiotherapists, speech and language therapists, and dieticians. This team approach aids in maximizing recovery and minimizing complications.
Early recognition and prompt management of stroke can significantly improve outcomes. Healthcare professionals play a vital role in this process, and their understanding of stroke signs and management strategies is paramount. Continuous education and training in stroke care are imperative to ensure the highest quality of care for these patients.
1.
The White House has postponed its plan to outlaw menthol cigarettes indefinitely.
2.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
3.
Distinct results for patients with positive and negative pancreatic cancer who are treated with systemic therapy, chemotherapy, and radiation.
4.
Artificial intelligence is assisting in the earlier detection and treatment of breast cancer.
5.
Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma
1.
Understanding the Importance of Knowing Your MCV Normal Range
2.
Modern Concepts in Oncology Across Clinical Settings
3.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
4.
Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development
5.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation